ATE164883T1 - Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen - Google Patents

Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen

Info

Publication number
ATE164883T1
ATE164883T1 AT93902352T AT93902352T ATE164883T1 AT E164883 T1 ATE164883 T1 AT E164883T1 AT 93902352 T AT93902352 T AT 93902352T AT 93902352 T AT93902352 T AT 93902352T AT E164883 T1 ATE164883 T1 AT E164883T1
Authority
AT
Austria
Prior art keywords
pct
double stranded
stranded rna
applications
date jun
Prior art date
Application number
AT93902352T
Other languages
English (en)
Inventor
Thierry Livache
Brigitte Fouque
Robert Teoule
Original Assignee
Cis Bio Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cis Bio Int filed Critical Cis Bio Int
Application granted granted Critical
Publication of ATE164883T1 publication Critical patent/ATE164883T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT93902352T 1991-12-18 1992-12-18 Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen ATE164883T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9115710A FR2685346B1 (fr) 1991-12-18 1991-12-18 Procede de preparation d'arn double-brin, et ses applications.

Publications (1)

Publication Number Publication Date
ATE164883T1 true ATE164883T1 (de) 1998-04-15

Family

ID=9420171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902352T ATE164883T1 (de) 1991-12-18 1992-12-18 Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen

Country Status (7)

Country Link
US (1) US5795715A (de)
EP (1) EP0618966B1 (de)
JP (1) JP3515108B2 (de)
AT (1) ATE164883T1 (de)
DE (1) DE69225074T2 (de)
FR (1) FR2685346B1 (de)
WO (1) WO1993012229A1 (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605712B1 (en) * 1990-12-20 2003-08-12 Arch Development Corporation Gene transcription and ionizing radiation: methods and compositions
FR2706465B1 (fr) * 1993-06-11 1995-08-25 Heliosynthese Sa Procédé de production et d'extraction de superoxyde-dismutases thermostables à partir d'une culture de micro-organismes photosynthétiques.
US20030055240A1 (en) * 1995-06-06 2003-03-20 Roberts Peter C. HPV specific oligonucleotides
US6509149B2 (en) * 1995-06-06 2003-01-21 Hybridon, Inc. HPV-specific oligonucleotides
US6458940B2 (en) * 1995-06-06 2002-10-01 Hybridon, Inc. HPV-specific oligonucleotides
US6274369B1 (en) * 1996-02-02 2001-08-14 Invitrogen Corporation Method capable of increasing competency of bacterial cell transformation
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
BRPI9908967B1 (pt) * 1998-03-20 2017-05-30 Benitec Australia Ltd processos para reprimir, retardar ou de outro modo reduzir a expressão de um gene alvo em uma célula de planta
AUPP249298A0 (en) * 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO2000044914A1 (en) * 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US20040138168A1 (en) * 1999-04-21 2004-07-15 Wyeth Methods and compositions for inhibiting the function of polynucleotide sequences
CA2370628A1 (en) * 1999-04-21 2000-10-26 American Home Products Corporation Methods and compositions for inhibiting the function of polynucleotide sequences
US7056661B2 (en) * 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1235842A4 (de) * 1999-10-15 2003-04-23 Univ Massachusetts Gene des rns-interferenzweges als hilfsmittel der gezielten gentischen interferenz
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
ATE450621T2 (de) 2000-03-30 2009-12-15 Whitehead Biomedical Inst Mediatoren von rns-interferenz, die rns- sequenzspezifisch sind
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
WO2003057926A1 (en) * 2002-01-08 2003-07-17 Chiron Corporation Gene products differentially expressed in cancerous breast cells and their methods of use
US6465217B1 (en) * 2000-07-05 2002-10-15 Paradigm Genetics, Inc. Methods and compositions for the modulation of chorismate synthase and chorismate mutase expression or activity in plants
US20080242627A1 (en) * 2000-08-02 2008-10-02 University Of Southern California Novel rna interference methods using dna-rna duplex constructs
US20020173478A1 (en) * 2000-11-14 2002-11-21 The Trustees Of The University Of Pennsylvania Post-transcriptional gene silencing by RNAi in mammalian cells
KR100872437B1 (ko) * 2000-12-01 2008-12-05 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
CA2369944A1 (en) * 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
US8034791B2 (en) 2001-04-06 2011-10-11 The University Of Chicago Activation of Egr-1 promoter by DNA damaging chemotherapeutics
US20040242523A1 (en) * 2003-03-06 2004-12-02 Ana-Farber Cancer Institue And The Univiersity Of Chicago Chemo-inducible cancer gene therapy
ATE541937T1 (de) * 2001-04-06 2012-02-15 Univ Chicago Chemotherapeutische einleitung der egr-1-promoter-aktivität in gentherapie
WO2004059289A2 (en) * 2001-05-22 2004-07-15 Epicentre Technologies Target-dependent transcription using deletion mutants of n4 rna polymerase
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna
TWI335938B (en) * 2001-08-15 2011-01-11 Rna replication and amplification
EP2189524A3 (de) 2001-11-09 2010-07-07 BASF Plant Science GmbH Proteinkinase-stressbedingte Polypeptide und Verwendungsverfahren für Pflanzen
ES2365912T3 (es) 2001-11-09 2011-10-13 Basf Plant Science Gmbh Polipéptidos del factor de transcripción relacionados con el estrés y métodos de uso en plantas.
EP3415625A1 (de) 2002-02-01 2018-12-19 Life Technologies Corporation Doppelsträngige oligonukleotide
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
WO2003064621A2 (en) 2002-02-01 2003-08-07 Ambion, Inc. HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
US20040248094A1 (en) * 2002-06-12 2004-12-09 Ford Lance P. Methods and compositions relating to labeled RNA molecules that reduce gene expression
AU2003276666A1 (en) * 2002-06-12 2003-12-31 Ambion, Inc. Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
AU2003257934A1 (en) 2002-08-01 2004-02-23 City Of Hope Methods and kits for synthesis of sirna expression cassettes
US7829694B2 (en) * 2002-11-26 2010-11-09 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US7618948B2 (en) 2002-11-26 2009-11-17 Medtronic, Inc. Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
US6852494B2 (en) * 2003-01-10 2005-02-08 Linden Technologies, Inc. Nucleic acid amplification
EP1604022A2 (de) * 2003-03-06 2005-12-14 Oligo Engine, Inc. Veränderung der genexpression mit dns-rns hybriden
EP1641930B1 (de) 2003-04-15 2011-06-29 BASF Plant Science GmbH Nukleinsäuresequenzen, die für proteine in zusammenhang mit abiotischer stressreaktion kodieren, sowie pflanzenzellen und pflanzen mit erhöhter umweltstressverträglichkeit
MXPA05012619A (es) * 2003-05-21 2006-02-08 Univ Texas Inhibicion de la proteina cinasa c-mu como un tratamiento para la hipertrofia cardiaca y la falla cardiaca.
WO2005095622A2 (en) * 2004-03-26 2005-10-13 Van Andel Research Institute c-met siRNA ADENOVIRUS VECTORS INHIBIT CANCER CELL GROWTH, INVASION AND TUMORIGENICITY
WO2005103254A1 (en) * 2004-04-22 2005-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem UNIVERSAL TARGET SEQUENCES FOR siRNA GENE SILENCING
NL1026335C2 (nl) * 2004-06-04 2005-12-06 Univ Delft Tech Werkwijze voor het maken van een dubbelstrengs polyribonucleotidenvolgorde met overhangend uiteinde, alsmede een werkwijze voor het vormen van een dubbelstrengs polynucleotidenconstruct en een toepassing.
AU2005286427B2 (en) 2004-09-24 2011-09-15 Basf Plant Science Gmbh Plant cells and plants with increased tolerance to environmental stress
CN103289961A (zh) 2004-09-24 2013-09-11 巴斯福植物科学有限公司 编码与非生物性胁迫反应相关的蛋白质的核酸序列和环境胁迫抗性增加的植物细胞和植物
US20060142228A1 (en) * 2004-12-23 2006-06-29 Ambion, Inc. Methods and compositions concerning siRNA's as mediators of RNA interference
DE202005004135U1 (de) * 2005-03-11 2005-05-19 Klocke Verpackungs-Service Gmbh Mehrkomponentenverpackung mit Applikator
CA2610644A1 (en) * 2005-05-31 2006-12-07 Devgen Nv Rnai for control of insects and arachnids
US7880055B2 (en) 2005-06-17 2011-02-01 Basf Plant Science Gmbh Lecitin-like protein kinase stress-related polypeptides and methods of use in plants
US8097769B2 (en) 2005-07-18 2012-01-17 Basf Plant Science Gmbh Yield increase in plants overexpressing the ACCDP genes
EP3222729A3 (de) 2005-07-18 2017-11-08 BASF Plant Science GmbH Erhöhung der wurzellänge bei arabidopsis-pflanzen zur überexpression von arabidopsis-shmt4 (shm4)-gene (at4g13930)
WO2007020198A2 (en) 2005-08-12 2007-02-22 Basf Plant Science Gmbh Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
US20070202515A1 (en) * 2005-10-12 2007-08-30 Pathologica, Llc. Promac signature application
WO2007092471A2 (en) * 2006-02-03 2007-08-16 The Regents Of The University Of California Methods for inhibition of lymphangiogenesis and tumor metastasis
MX2008012252A (es) 2006-03-24 2009-01-14 Basf Plant Science Gmbh Proteinas que se relacionan con la respuesta al estres abiotico y homologos.
SI2056845T1 (en) 2006-08-08 2018-02-28 Rheinische Friedrich-Wilhelms-Universitaet Bonn STRUCTURE AND USE 5 'PHOSPHATE OF OLIGONUCLEOTES
US8344205B2 (en) 2006-10-13 2013-01-01 Basf Plant Science Gmbh Plants with increased yield
CA2675926A1 (en) 2007-02-16 2008-08-21 Basf Plant Science Gmbh Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants
AR067318A1 (es) 2007-05-22 2009-10-07 Basf Plant Science Gmbh Plantas con mayor tolerancia y/o resistencia aumentada al estres ambiental y mayor produccion de biomasa
CA2688061A1 (en) * 2007-05-23 2008-12-04 Mannkind Corporation Multicistronic vectors and methods for their design
AU2008300579B2 (en) 2007-09-18 2014-11-13 Basf Plant Science Gmbh Plants with increased yield
EP2594646A3 (de) 2007-09-21 2013-11-06 BASF Plant Science GmbH Pflanze mit erhöhtem Ertrag
AU2008337398B2 (en) 2007-12-19 2014-04-03 Basf Plant Science Gmbh Plants with increased yield and/or increased tolerance to environmental stress (IY-BM)
WO2009094647A2 (en) 2008-01-25 2009-07-30 Introgen Therapeutics, Inc. P53 biomarkers
WO2009097508A2 (en) 2008-01-30 2009-08-06 Mcanulty, Jonathan Methods and compositions for wound healing
US20110010800A1 (en) * 2008-02-27 2011-01-13 Basf Plant Science Gmbh Plants with increased yield
EP2297323A1 (de) 2008-05-21 2011-03-23 Hartmann, Gunther 5 -triphosphat-oligonukleotid mit stumpfem ende und verwendugen davon
EP2352822A2 (de) 2008-08-19 2011-08-10 BASF Plant Science GmbH Pflanzen mit erhöhtem ertrag mittels steigerung oder erzeugung von einer oder mehreren aktivitäten in der pflanze oder einem teil dieser
BRPI0919153A2 (pt) 2008-09-23 2019-05-07 Basf Plant Science Gmbh método para produzir uma planta com rendimento aumentado, molécula de ácido nucleico, construto de ácido nucleico, vetor, processo para produzir um polipeptídeo, poliptídeo, anticorpo, núcleo de célula de planta, célula de planta, tecido de planta, material de propagação, pólen, progênie, material coletado, ou uma planta, ou uma parte da planta, planta transgênica, processo para identificar um composto, método para a produção de uma composição agrícola, composição, uso de ácido nucleico, e, método para a identificação de uma planta com um rendimento aumentado, e para aumentar o rendimento de uma população de plantas
CN104745624A (zh) 2008-10-23 2015-07-01 巴斯夫植物科学有限公司 生产具有增加的γ-氨基丁酸(GABA)含量的转基因细胞的方法
MX2011004270A (es) 2008-10-23 2011-07-13 Basf Plant Science Gmbh Plantas con rendimiento aumentado (nue).
EP2186822A1 (de) 2008-11-07 2010-05-19 Sanofi-Aventis Verwendung von Inhibitoren der Plac8-Aktivität zur Modulation von Adipogenese
EP2236607A1 (de) 2009-04-02 2010-10-06 Sanofi-Aventis Verwendung von Hemmern der St3Gla6-Aktivität zur Adipogenesemodulation
EP2253705A1 (de) 2009-05-20 2010-11-24 Sanofi-Aventis Verwendung von Hemmern der Zdhhc2-Aktivität zur Adipogenesemodulation
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
US20120117867A1 (en) 2009-07-23 2012-05-17 Basf Plant Science Company Gmbh Plants with Increased Yield
EP2308892A1 (de) 2009-10-01 2011-04-13 Sanofi-Aventis Verwendung von siRNA gegen Sipa1l1 zur Reduzierung von Lipogenese
AU2010320547B2 (en) 2009-11-17 2016-06-09 Basf Plant Science Company Gmbh Plants with increased yield
WO2011094731A2 (en) 2010-02-01 2011-08-04 The Board Of Trustees Of The Leland Stanford Junior University Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus
WO2013005211A2 (en) 2011-07-05 2013-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Boron complexing plant materials and uses thereof cross-reference to related applications
US10040853B2 (en) 2011-09-09 2018-08-07 Fred Hutchinson Cancer Research Center Methods and compositions involving NKG2D inhibitors and cancer
WO2014045126A2 (en) 2012-09-18 2014-03-27 Uti Limited Partnership Treatment of pain by inhibition of usp5 de-ubiquitinase
EP2712870A1 (de) 2012-09-27 2014-04-02 Rheinische Friedrich-Wilhelms-Universität Bonn Neuartige RIG-I-Liganden und Herstellungsverfahren dafür
JP6334550B2 (ja) 2012-11-06 2018-05-30 インベッド バイオサイエンシズ，インコーポレイテッド 創傷治癒の方法と組成物
EP2961853B1 (de) 2013-02-28 2018-09-19 The Board of Regents of The University of Texas System Verfahren zur klassifizierung einer krebserkrankung als anfälligkeit für tmepai-gerichtete therapien und zur heilung solcher krebserkrankungen
EP3065775B1 (de) 2013-11-08 2020-09-30 The Board of Regents of the University of Texas System Vh4-antikörper gegen und neuron und astrozyt der grauen substanz
WO2016025629A1 (en) 2014-08-12 2016-02-18 The Regents Of The University Of California Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues
WO2016025202A1 (en) 2014-08-14 2016-02-18 The Regents Of The University Of Colorado Antibody-sirna conjugates and uses therefor
CN107921188A (zh) 2015-05-18 2018-04-17 小利兰·斯坦福大学托管委员会 用于治疗衰老相关的损伤的方法和组合物
EP3144014A1 (de) 2015-09-21 2017-03-22 Commissariat A L'energie Atomique Et Aux Energies Alternatives Synthetische tödliche arzneimittelkombination zur behandlung von nierenzellenkarzinom
KR102899445B1 (ko) 2016-07-29 2025-12-15 임베드 바이오사이언시스 아이엔씨. 상처 치유를 위한 방법 및 조성물
US11286301B2 (en) 2017-02-28 2022-03-29 The Board Of Trustees Of The Leland Stanford Junior University Antifibrotic activity of CD47 blockade
MX2020002872A (es) 2017-09-15 2020-10-05 Commw Scient Ind Res Org Moléculas de arn.
ES2975662T3 (es) 2018-10-31 2024-07-11 Univ Arizona Biomarcadores y métodos de uso para la lesión pulmonar inducida por radiación
CN115989415A (zh) 2020-06-30 2023-04-18 健肺生命人工智能公司 用于检测肺癌的方法
WO2023230531A1 (en) 2022-05-24 2023-11-30 Lunglife Ai, Inc. Methods for detecting circulating genetically abnormal cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
JPH05503422A (ja) * 1990-01-10 1993-06-10 バイエル　コーポレイション 核酸ハイブリダイゼーションアッセイでの信号増幅用レポーター分子としてのｄｎａ依存性ｒｎａポリメラーゼ転写産物

Also Published As

Publication number Publication date
US5795715A (en) 1998-08-18
FR2685346B1 (fr) 1994-02-11
DE69225074D1 (de) 1998-05-14
FR2685346A1 (fr) 1993-06-25
JPH07505762A (ja) 1995-06-29
WO1993012229A1 (fr) 1993-06-24
DE69225074T2 (de) 1998-10-29
EP0618966B1 (de) 1998-04-08
JP3515108B2 (ja) 2004-04-05
EP0618966A1 (de) 1994-10-12

Similar Documents

Publication Publication Date Title
DE69225074D1 (de) Verfahren zur vorbereitung von doppel strangiger rna und seine anwendungen
AU692403B2 (en) Analysis of gene expression by display of 3'-end restriction fragments of cdnas
EP0777747B1 (de) Nukleotid-sequenzierungsmethode
DE69307503D1 (de) Chemisches verfahren zur analyse von dns-sequenzen
DE68925717D1 (de) Verfahren und Reagenzkombination zur Bestimmung von Nukleotidsequenzen
EP1757694A3 (de) Prostata-spezifisches Membranantigen
ATE73502T1 (de) Verfahren und ausstattung zur bestimmung von spezifischen nukleotid-variationen und genetischen polymorphismen in nukleinsaeuren.
ATE204332T1 (de) Positionelle sequenzierung durch hybridisierung
EP0969102A3 (de) Primer, Sätze und Restriktions Fragmente und dessen Benutzung in selektive Restriktionsfragmentenamplifikation
EP0359789A1 (de) Verstärkung und nachweis von nukleinsäuresequenzen.
DE60220025D1 (de) Methoden und zusammensetzungen zur vervielfältigung von rna sequenzen
DE69428252D1 (de) Verfahren zur Verbesserung der Nukleinsäureamplifizierung
WO1993016094A3 (en) Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides
AU1022488A (en) T7 dna polymerase
WO1998026093A3 (en) Fluorescent nucleotide analog hairpin formation for detection of nucleic acid hybridization
DE60116651D1 (de) Methode zur amplifizierung und möglicher charakterisierung von nukleinsäuren
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
CA2264967A1 (en) Method of dna sequencing
DE69815370D1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen
WO2001088196A3 (en) Sequence based screening
WO2000026406A1 (en) METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAs
WO2002072881A3 (en) Method for the amplification and detection of hbv dna using a transcription based amplification
EP0286958A3 (de) Verfahren und Mittel zur Bestimmung von Nucleinsäuren
WO2005059505A3 (es) Método y kit para genotipificación de hla-b27 basados en la pcr en tiempo real
Palmirotta et al. Origin and gender determination of dried blood on a statue of the Virgin Mary